1. Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models. (1st April 2021) Authors: Wicker, Christina A.; Hunt, Brian G.; Krishnan, Sunil; Aziz, Kathryn; Parajuli, Shobha; Palackdharry, Sarah; Elaban, William R.; Wise-Draper, Trisha M.; Mills, Gordon B.; Waltz, Susan E.; Takiar, Vinita Journal: Cancer letters Issue: Volume 502(2021) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗